Publication: Efficacy and Persistence Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Kermode, Allan/0000-0002-4476-4016;
Keywords
Citation
WoS Q
Q1
Scopus Q
Q1
Source
Multiple Sclerosis Journal
Volume
28
Issue
Start Page
645
End Page
647